Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 747 across all filing types
Latest filing 2022-11-10 Call Transcript
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 95% confidence The document is an invitation and intimation for an Investor's Conference Call scheduled to discuss the company's financial performance for the quarter and half-year ended 30th September 2022. It is addressed to stock exchanges and includes call details and participant names. There is no actual financial data or report content included, only an announcement of the call. Therefore, this document is best classified as a Call Transcript (CT) type, specifically the announcement of a conference call related to financial results.
2022-11-10 English
Board Meeting — Financial results
Regulatory Filings Classification · 100% confidence The document text is extremely short (92 characters) and contains only a digital signature with a date, without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. This matches the pattern of a certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-11-05 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is a detailed credit rating disclosure and press release issued by CARE Ratings Limited regarding the credit rating of SMS Pharmaceuticals Limited's enhanced bank facilities. It includes financial data, rating rationale, key rating drivers, financial risk profile, industry outlook, and detailed descriptions of the company's operations and financials. The document is addressed to stock exchanges and complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is not a full annual or quarterly report but a credit rating update and analysis. This type of document fits best under Regulatory Filings (RNS) as it is a regulatory disclosure related to credit rating and financial status, not a full financial report or earnings release. The document length is substantial (15,000 characters), and it contains detailed financial and operational information but is primarily a credit rating disclosure rather than a financial report or earnings release.
2022-11-03 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the acquisition of a 4.9% capital contribution in M/s. Provenio Astral International LLP. It details the target entity, nature of the acquisition, consideration, and completion date. The content focuses on a capital investment transaction rather than financial results, management changes, or regulatory certifications. The document length is 2853 characters, which is relatively short and contains detailed information about the acquisition transaction. This fits the definition of a Capital/Financing Update (CAP) as it provides an update on company fundraising or capital structure changes.
2022-10-18 English
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2022. It is a compliance certificate issued by the Registrar and Share Transfer Agent and addressed to stock exchanges. The document length is short (1167 characters) and it is a certification letter rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the category of Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a full report or announcement of a report.
2022-10-11 English
Credit Rating
Audit Report / Information Classification · 95% confidence The document is a detailed credit rating disclosure and press release from CARE Ratings Limited regarding the credit rating assigned to SMS Pharmaceuticals Limited's bank facilities. It includes financial performance data, rating rationale, key rating drivers, financial risk profile, industry outlook, and detailed financials for fiscal years and quarters. The document is not an annual report or earnings release but a credit rating report, which is a type of audit or financial information related to creditworthiness and risk assessment. It is not a simple announcement or certification but contains substantive financial and operational analysis. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles and results of internal or regulatory stress tests, excluding full annual reports.
2022-10-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.